Posanski; Ulrich
Patent Applications and Registrations
Patent applications and USPTO patent grants for Posanski; Ulrich.The latest application filed is for "novel cyclosporin galenic forms".
- Posanski; Ulrich - Freiburg DE
- Posanski; Ulrich - D-7800 Freiburg DE
- Posanski; Ulrich - Roesrath DE
| Patent | Date |
|---|---|
| Cyclosporin galenic forms Grant 7,511,014 - Cavanak , et al. March 31, 2 | 2009-03-31 |
| Pharmaceutical compositions comprising cyclosporins Grant 7,235,248 - Hauer , et al. June 26, 2 | 2007-06-26 |
| Novel cyclosporin galenic forms App 20070042943 - Cavanak; Thomas ; et al. | 2007-02-22 |
| Cyclosporin galenic forms Grant 7,081,445 - Cavanak , et al. July 25, 2 | 2006-07-25 |
| Pharmaceutical compositions for sparingly soluble therapeutic agents App 20050048087 - Posanski, Ulrich | 2005-03-03 |
| Pharmaceutical Composition Grant 6,844,459 - Hauer , et al. January 18, 2 | 2005-01-18 |
| Novel cyclosporin galenic forms App 20040167063 - Cavanak, Thomas ; et al. | 2004-08-26 |
| Pharmaceutical compositions for sparingly soluble therapeutic agents App 20040019074 - Posanski, Ulrich | 2004-01-29 |
| Pharmaceutical composition App 20030199433 - Hauer, Birgit ; et al. | 2003-10-23 |
| Pharmaceutical compositions comprising cyclosporins App 20030143250 - Hauer, Birgit ; et al. | 2003-07-31 |
| Pharmaceutical composition App 20030104990 - Hauer, Birgit ; et al. | 2003-06-05 |
| Novel cyclosporin galenic forms App 20030060402 - Cavanak, Thomas ; et al. | 2003-03-27 |
| Pharmaceutical preparations for the targeted treatment of crohn's disease and ulcerative colitis Grant 6,503,883 - Posanski January 7, 2 | 2003-01-07 |
| Cyclosporin galenic forms Grant 6,468,968 - Cavanak , et al. October 22, 2 | 2002-10-22 |
| Pharmaceutical compositions for sparingly soluble therapeutic agents App 20020099067 - Posanski, Ulrich | 2002-07-25 |
| Novel cyclosporin galenic forms App 20020013272 - Cavanak, Thomas ; et al. | 2002-01-31 |
| Pharmaceutical composition App 20010036918 - Hauer, Birgit ; et al. | 2001-11-01 |
| Pharmaceutical preparations for the targeted treatment of crohn's disease and ulcerative colitis Grant 6,204,243 - Posanski March 20, 2 | 2001-03-20 |
| Pharmaceutical compositions comprising cyclosporins Grant 6,024,978 - Hauer , et al. February 15, 2 | 2000-02-15 |
| Pharmaceutical compositions comprising cyclosporins Grant 6,007,840 - Hauer , et al. December 28, 1 | 1999-12-28 |
| Pharmaceutical compositions comprising cyclosporins Grant 5,962,017 - Hauer , et al. October 5, 1 | 1999-10-05 |
| Pharmaceutical compositions comprising cyclosporins Grant 5,962,014 - Hauer , et al. October 5, 1 | 1999-10-05 |
| Pharmaceutical compositions comprising cyclosporins Grant 5,916,589 - Hauer , et al. June 29, 1 | 1999-06-29 |
| Pharmaceutical compositions comprising cyclosporins Grant 5,866,159 - Hauer , et al. February 2, 1 | 1999-02-02 |
| Water soluble monoesters as solubilisers for pharmacologically active compounds and pharmaceutical excipients and novel cyclosporin galenic forms Grant 5,756,450 - Hahn , et al. May 26, 1 | 1998-05-26 |
| Pharmaceutical compositions comprising cyclosporins Grant 5,741,512 - Hauer , et al. April 21, 1 | 1998-04-21 |
| Cyclosporin galenic forms Grant 5,652,212 - Cavanak , et al. July 29, 1 | 1997-07-29 |
| Pharmaceutical compositions comprising cyclosporins Grant 5,342,625 - Hauer , et al. August 30, 1 | 1994-08-30 |
| Dihydropyridine preparations containing .beta.-blockers Grant 4,794,111 - Posanski , et al. December 27, 1 | 1988-12-27 |
| Liquid active ingredient concentrates for preparation of microemulsions Grant 4,567,161 - Posanski , et al. January 28, 1 | 1986-01-28 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 